|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
Mergers from Amgen, Onyx and TMS International aren't enough to persuade stocks to move higher. Qihoo investors are happy with its earnings.
It's an honor to fill in for the one and only Doug Kass here on the Diary. Here's what's happening: Futures are offered slightly lower in early trading. Metals are consolidating gains after last week's torrid rally. Onyx Pharmaceutical (ONXX) agreed...
Department store chain Kohl's reports second-quarter results that narrowly misses analysts' expectations.
Jim Cramer looks at the latest biotech deals as Cubist acquires Trius amid changes among Biotech companies.
There have been some really good winners this year. By Bob Lang One of the best sectors to play this year has been the biotechs and I would be remiss if I didn't tell you my best play ever was just a couple weeks ago with Onyx Pharmaceutical (ONXX),...
Expect hospital and biotech deals to dominate during the second half of 2013, says Gerald Adolph, Sr. Partner at Booz & Company.
Thanks to handwringing about macro issues, I missed one of the hottest IPOs in recent memory.
Once the sidelined money realizes their stocks have done better than their bonds, they'll come back in.
Onyx's deal with Pfizer will be a sweetener as bidding for the biotech gets more intense, says Adam Feuerstein, senior columnist at TheStreet.
Onyx Pharmaceuticals says no to a takeover bid from biotech company Amgen. TheStreet's Brittany Umar has details in Monday's Ahead of the Ticker.
Stocks get July started in positive territory as Onyx rejects Amgen, Apple trademarks the iWatch and Nokia takes ownership of its networks.
Here is my compilation of last night's profit reports. 24 beats: W&T Offshore (WTI) Oasis Petroleum (OAS) Marathon Oil (MRO) Huntington Ingalls Industries (HII) Cognizant Technology Solutions (CTSH) Disney (DIS) Electronic Arts (EA) Regency Centers ...
The S&P looks set to hit another lofty level, even as it remains unsupported by fundamentals.
Deep-in-the-money call options on these five names could provide a healthy return.
Brittany Umar and Scott Redler, chief strategic officer at T3Live.com, reveal how to trade stocks ahead of earnings season: retail, banks, tech.